Israel Non-Small Cell Lung Cancer Therapeutics Market (2025-2031) | Growth, Outlook, Trends, Share, Companies, Forecast, Industry, Value, Segmentation, Size & Revenue, Competitive Landscape, Analysis

2.1 Key Highlights of the Report

2.2 Report Description

2.3 Market Scope & Segmentation

2.4 Research Methodology

2.5 Assumptions

3.1 Israel Country Macro Economic Indicators

3.2 Israel Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, 2021 & 2031F

3.3 Israel Non-Small Cell Lung Cancer Therapeutics Market - Industry Life Cycle

3.4 Israel Non-Small Cell Lung Cancer Therapeutics Market - Porter's Five Forces

3.5 Israel Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume Share, By Therapy, 2021 & 2031F

3.6 Israel Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F

3.7 Israel Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F

4.1 Impact Analysis

4.2 Market Drivers

4.2.1 Increasing incidence of non-small cell lung cancer in Israel

4.2.2 Advancements in research and development of targeted therapies

4.2.3 Growing investments in healthcare infrastructure and facilities

4.3 Market Restraints

4.3.1 High costs associated with non-small cell lung cancer therapeutics

4.3.2 Stringent regulatory requirements for drug approval in Israel

6.1 Israel Non-Small Cell Lung Cancer Therapeutics Market, By Therapy

6.1.1 Overview and Analysis

6.1.2 Israel Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Therapy, 2021- 2031F

6.1.3 Israel Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Targeted Therapy, 2021- 2031F

6.1.4 Israel Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Immunotherapy, 2021- 2031F

6.1.5 Israel Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Chemotherapy, 2021- 2031F

6.2 Israel Non-Small Cell Lung Cancer Therapeutics Market, By Distribution Channel

6.2.1 Overview and Analysis

6.2.2 Israel Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F

6.2.3 Israel Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F

6.2.4 Israel Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Online Pharmacies, 2021- 2031F

6.2.5 Israel Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Others, 2021- 2031F

6.3 Israel Non-Small Cell Lung Cancer Therapeutics Market, By Cancer Type

6.3.1 Overview and Analysis

6.3.2 Israel Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Adenocarcinoma, 2021- 2031F

6.3.3 Israel Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Squamous cell carcinoma, 2021- 2031F

6.3.4 Israel Non-Small Cell Lung Cancer Therapeutics Market Revenues & Volume, By Large cell carcinoma, 2021- 2031F

7.1 Israel Non-Small Cell Lung Cancer Therapeutics Market Export to Major Countries

7.2 Israel Non-Small Cell Lung Cancer Therapeutics Market Imports from Major Countries

8.1 Average survival rate of non-small cell lung cancer patients in Israel

8.2 Adoption rate of innovative therapies in the market

8.3 Number of clinical trials and research studies conducted in Israel for non-small cell lung cancer therapeutics

9.1 Israel Non-Small Cell Lung Cancer Therapeutics Market Opportunity Assessment, By Therapy, 2021 & 2031F

9.2 Israel Non-Small Cell Lung Cancer Therapeutics Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F

9.3 Israel Non-Small Cell Lung Cancer Therapeutics Market Opportunity Assessment, By Cancer Type, 2021 & 2031F

10.1 Israel Non-Small Cell Lung Cancer Therapeutics Market Revenue Share, By Companies, 2024

10.2 Israel Non-Small Cell Lung Cancer Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters